Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Equity Ratio (2020 - 2023)

Terns Pharmaceuticals' Equity Ratio history spans 4 years, with the latest figure at 0.95 for Q3 2023.

  • For Q3 2023, Equity Ratio changed 0.28% year-over-year to 0.95; the TTM value through Sep 2023 reached 0.95, changed 0.28%, while the annual FY2022 figure was 0.96, 1.16% up from the prior year.
  • Equity Ratio reached 0.95 in Q3 2023 per TERN's latest filing, up from 0.95 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.96 in Q4 2022 to a low of 1.27 in Q4 2020.
  • Average Equity Ratio over 4 years is 0.77, with a median of 0.95 recorded in 2021.
  • Peak YoY movement for Equity Ratio: surged 174.95% in 2021, then decreased 1.79% in 2022.
  • A 4-year view of Equity Ratio shows it stood at 1.27 in 2020, then soared by 174.95% to 0.95 in 2021, then increased by 1.16% to 0.96 in 2022, then decreased by 1.42% to 0.95 in 2023.
  • Per Business Quant, the three most recent readings for TERN's Equity Ratio are 0.95 (Q3 2023), 0.95 (Q2 2023), and 0.95 (Q1 2023).